With few population-based studies assessing vasculitis-related mortality, most of which are limited to vasculitis subtypes, researchers examined time trends in in-hospital mortality in patients with vasculitis and compared these trends with those among the general US population using the U.S. National Inpatient Sample (NIS) from 1998-2014. The study team calculated unadjusted in-hospital mortality rates per 1,000 hospitalizations for people with versus without primary vasculitis hospitalizations. Unadjusted in-hospital mortality in primary vasculitis hospitalizations decreased by 43%, from 32.8 per 1,000 in 1998 to 18.7 per 1,000 in 2014, compared with a 24.5% reduction in deaths for all NIS claims without vasculitis, from 28.1 to 21.2 per 1,000. Age- and sex-adjusted in-hospital mortality decreased in primary vasculitis hospitalizations, from 27.3 per 1,000 claims in 1998 to 19.1 in 2014, as well as in non-vasculitis hospitalizations, from 15.1 to 13.2 per 1,000 in 2014. These rates occurred despite primary vasculitis hospitalizations per year remaining fairly constant throughout the study period. The age- and sex-adjusted mortality rate gap between those with versus without vasculitis narrowed.
SABC 202043RD虚拟San Antonio乳腺癌癌症研讨会（SABCS®）将于2020年12月8日至11日举行。该SABC是基础，翻译和临床癌症研究专业人员的首要会议。众所周知，为来自世界各地的最新乳腺癌数据呈现。
ACC 2020由于Covid-19，美国心脏病学决定取消ACC.20 / WCC，该19次被安排在芝加哥3月28日至30日举行。然而，ACC.20 / WCC虚拟会议继续释放尖端科学，并在6月20日至6月自由地免费释放心血管专业人员的更改更新。
endo：2020Endo 2020年会因Covid-19而取消。以下是仍在释放的新兴数据的亮点。留意Endo Online 2020，将于6月8日至22日举行。